Effects of Upper Extremity Rehabilitation Robot and Transcranial Direct Current Stimulation Among Patients With Stroke

August 12, 2019 updated by: Joon-Ho Shin, National Rehabilitation Center, Seoul, Korea

Effects of Upper Extremity Rehabilitation Robot and Transcranial Direct Current Stimulation on Upper Extremity Function Among Subjects With Tremor After Cerebellar and Brainstem Stroke

Effects of upper extremity rehabilitation robot and transcranial direct current stimulation on upper extremity function among subjects with tremor after stroke

Study Overview

Status

Unknown

Conditions

Study Type

Interventional

Enrollment (Anticipated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Seoul, Korea, Republic of, 142884
        • Recruiting
        • National Rehabilitation Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Stroke with cerebellar hemorrhage or infarction
  • ataxia or tremor on upper extremities secondary to stroke
  • Cognitively intact enough to understand and follow the instructions from the investigator

Exclusion Criteria:

  • History of surgery of affected upper limb
  • Fracture of affected upper limb

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Robot and tDCS on-line
Combined transcranial direct current stimulation(tDCS) on-line and upper extremity rehabilitation robot
Combined transcranial direct current stimulation(tDCS) on-line and upper extremity rehabilitation robot for 5 times a week for 4 weeks
Sham Comparator: Robot and sham tDCS
Combined sham tDCS and upper extremity rehabilitation robot
Combined sham tDCS and upper extremity rehabilitation robot for 5 times a week for 4 weeks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of Scale for the assessment and rating of ataxia
Time Frame: Change of Scale for the assessment and rating of ataxia at 4 weeks after baseline compared to baseline
Change of Scale for the assessment and rating of ataxia
Change of Scale for the assessment and rating of ataxia at 4 weeks after baseline compared to baseline
Change of Functional ataxia rating scale - upper limb
Time Frame: Change of the Functional ataxia rating scale - upper limb, at 4 weeks after baseline compared to baseline
Change of Functional ataxia rating scale - upper limb
Change of the Functional ataxia rating scale - upper limb, at 4 weeks after baseline compared to baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fugl-Meyer Assessment - upper extremity
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Fugl-Meyer Assessment - upper extremity
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Composite cerebellar functional severity score
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Composite cerebellar functional severity score (Nine hole peg test + click test)
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Jerk during reaching and finger pointing
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Kinematic data during reaching and finger pointing using Trakstar
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Smoothness during reaching and finger pointing
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Kinematic data during reaching and finger pointing using Trakstar
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Behavioral activation system/behavioral inhibition system scale
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
In terms of motivation
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Beck's depression index
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Beck's depression index
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Stroke rehabilitation motivation scale
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Stroke rehabilitation motivation scale
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Intrinsic motivation inventory
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Intrinsic motivation inventory
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Numeric rating scale for upper extremity pain
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Question about the upper extremity pain (0-10; higher is better)
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Functional reaching test
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Functional reaching test
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
modified Barthel index
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
modified Barthel index
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
% maximal voluntary contraction from upper extremity muscles during reaching task
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
data from surface electromyography from upper extremity muscles during reaching task
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Kinematic data during scale for the assessment and rating of ataxia
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Kinematic data during scale for the assessment and rating of ataxia
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Scale for the assessment and rating of ataxia
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Scale for the assessment and rating of ataxia
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Functional ataxia rating scale - upper limb
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Functional ataxia rating scale - upper limb, kinematic data during scale for the assessment
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Kinematic data during scale during the Functional ataxia rating scale - upper limb
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
Kinematic data during scale during the Functional ataxia rating scale - upper limb
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2017

Primary Completion (Anticipated)

December 31, 2019

Study Completion (Anticipated)

December 31, 2019

Study Registration Dates

First Submitted

March 1, 2018

First Submitted That Met QC Criteria

August 12, 2019

First Posted (Actual)

August 14, 2019

Study Record Updates

Last Update Posted (Actual)

August 14, 2019

Last Update Submitted That Met QC Criteria

August 12, 2019

Last Verified

August 1, 2019

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Robot and tDCS on-line

3
Subscribe